Ray Dalio Jazz Pharmaceuticals PLC Transaction History
Bridgewater Associates, LP
- $19.6 Billion
- Q1 2024
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Bridgewater Associates, LP holds 109,791 shares of JAZZ stock, worth $11.6 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
109,791
Previous 90,416
21.43%
Holding current value
$11.6 Million
Previous $11.1 Million
18.88%
% of portfolio
0.07%
Previous 0.06%
Shares
10 transactions
Others Institutions Holding JAZZ
# of Institutions
515Shares Held
57.1MCall Options Held
65.9KPut Options Held
183K-
Black Rock Inc. New York, NY7.07MShares$744 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.45MShares$679 Million0.02% of portfolio
-
State Street Corp Boston, MA2.46MShares$259 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.38MShares$251 Million0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY1.49MShares$157 Million0.02% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.6B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...